Company registration number: 11468735
Unaudited financial statements
for the year ended 31 July 2024
for
Nadclinic Ltd
Pages for filing with the Registrar
Company registration number: 11468735
Nadclinic Ltd
Balance sheet
as at 31 July 2024
2024 2023
Note £ £ £ £
Fixed assets
Intangible assets 4 231,873 169,384
Tangible assets 5 25,854 44,229
257,727 213,613
Current assets
Stocks 14,703 23,370
Debtors 557,331 349,389
Cash at bank and in hand 67,954 28,629
639,988 401,388
Creditors: amounts falling due within one
year
(550,737) (324,371)
Net current assets 89,251 77,017
Total assets less current liabilities 346,978 290,630
Creditors: Amounts falling due after more
than one year
(261,615) (267,301)
NET ASSETS 85,363 23,329
Capital and reserves
Called up share capital 250,100 250,100
Profit and loss account (164,737) (226,771)
TOTAL EQUITY 85,363 23,329
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 July 2024.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 11468735
Nadclinic Ltd
Balance sheet - continued
as at 31 July 2024
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
Signed by:
Ms Y Feng, Director
29 April 2025
2
Nadclinic Ltd
Notes to the financial statements
for the year ended 31 July 2024
1 Company information
Nadclinic Ltd is a private company registered in England and Wales. Its registered number is 11468735. The company is limited by shares. Its registered office is Floor 1, 27 Wimpole Street, London, W1G 8GN.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the director has assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the director takes into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The director considers that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Amortisation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Development costs - 10% straight line
Software - 25% straight line
3
Nadclinic Ltd
Notes to the financial statements - continued
for the year ended 31 July 2024
2 Accounting policies - continued
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Land and buildings:
Leasehold Improvements - 20% straight line
Plant and machinery etc.:
Plant and equipment - 25% straight line
Fixtures & fittings - 25% straight line
Computer equipment - 25% straight line
Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Taxation
Taxation for the year comprises current and deferred taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that been enacted or substantively enacted by the balance sheet date and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probably that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit and loss in the period to which they relate.
3 Average number of employees
During the year the average number of employees was 11 (2023 - 11).
4
Nadclinic Ltd
Notes to the financial statements - continued
for the year ended 31 July 2024
4 Intangible assets
Other
intangible
assets
£
Cost
At 1 August 2023 204,099
Additions 93,424
At 31 July 2024 297,523
Amortisation
At 1 August 2023 34,715
Charge for year 30,935
At 31 July 2024 65,650
Net book value
At 31 July 2024 231,873
At 31 July 2023 169,384
5 Tangible fixed assets
Land and
buildings
Plant and
machinery
etc.
Totals
£ £ £
Cost
At 1 August 2023 53,505 73,326 126,831
Additions - 3,992 3,992
At 31 July 2024 53,505 77,318 130,823
Depreciation
At 1 August 2023 33,009 49,593 82,602
Charge for year 10,242 12,125 22,367
At 31 July 2024 43,251 61,718 104,969
Net book value
At 31 July 2024 10,254 15,600 25,854
At 31 July 2023 20,496 23,733 44,229
5